Skip to main content
. Author manuscript; available in PMC: 2020 Aug 25.
Published in final edited form as: Clin Cancer Res. 2018 Apr 10;24(14):3423–3432. doi: 10.1158/1078-0432.CCR-17-3406

Figure 5.

Figure 5.

Schematic illustration of SDHB deficiency-associated drug resistance. Left, mitochondrial complex I and II supply coenzyme Q with electron. Electron transport chain maintains mitochondrial membrane potential and ATP generation. Right, in cancer cells with SDHB genetic deficiency, the loss of mitochondrial complex II-derived electron results in dependency on complex I. Upregulated NADH dehydrogenase activity alters NAD+/ NADH balance, resulting in increased NAD+ availability and enhanced PARP DNA repair. Targeting NAD+/PARP DNA repair pathway sensitizes SDHB-deficient PCPG to genotoxic agent such as TMZ.